Roche Holding AG (OTCMKTS:RHHBY) Shares Bought by Bard Financial Services Inc.

Bard Financial Services Inc. boosted its position in shares of Roche Holding AG (OTCMKTS:RHHBY) by 25.3% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 138,900 shares of the company’s stock after acquiring an additional 28,050 shares during the period. Bard Financial Services Inc.’s holdings in Roche were worth $5,716,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in RHHBY. HighPoint Advisor Group LLC raised its position in Roche by 2.8% in the 4th quarter. HighPoint Advisor Group LLC now owns 11,091 shares of the company’s stock valued at $387,000 after purchasing an additional 304 shares during the last quarter. Fulton Bank N.A. raised its position in Roche by 2.6% during the 1st quarter. Fulton Bank N.A. now owns 12,620 shares of the company’s stock worth $518,000 after buying an additional 314 shares during the last quarter. Confluence Investment Management LLC raised its position in Roche by 3.6% during the 1st quarter. Confluence Investment Management LLC now owns 14,491 shares of the company’s stock worth $596,000 after buying an additional 510 shares during the last quarter. Altrius Capital Management Inc raised its position in Roche by 0.3% during the 4th quarter. Altrius Capital Management Inc now owns 183,448 shares of the company’s stock worth $6,399,000 after buying an additional 603 shares during the last quarter. Finally, Hancock Whitney Corp raised its position in Roche by 6.8% during the 4th quarter. Hancock Whitney Corp now owns 23,516 shares of the company’s stock worth $820,000 after buying an additional 1,496 shares during the last quarter.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on RHHBY shares. HSBC cut shares of Roche from a “buy” rating to a “hold” rating in a research note on Monday, April 28th. UBS Group raised shares of Roche from a “hold” rating to a “strong-buy” rating in a research note on Thursday, February 13th. Hsbc Global Res cut shares of Roche from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 28th. Finally, Morgan Stanley assumed coverage on shares of Roche in a research note on Wednesday, February 12th. They issued an “equal weight” rating on the stock. One analyst has rated the stock with a sell rating, three have given a hold rating, one has issued a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy”.

Roche Stock Performance

RHHBY opened at $41.07 on Wednesday. The firm’s 50 day moving average is $39.19 and its 200-day moving average is $38.94. Roche Holding AG has a 52-week low of $33.34 and a 52-week high of $44.31. The company has a current ratio of 1.26, a quick ratio of 0.97 and a debt-to-equity ratio of 0.86.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.